Product Images Atorvastatin Calcium

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Atorvastatin Calcium NDC 55154-6646 by Cardinal Health 107, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Figure 1: Effect of Atorvastatin Calcium 10 mg/day on Cumulative Incidence of Non-Fatal Myocardial Infarction or Coronary Heart Disease Death (in ASCOT-LLA) - Figure 1

Figure 1: Effect of Atorvastatin Calcium 10 mg/day on Cumulative Incidence of Non-Fatal Myocardial Infarction or Coronary Heart Disease Death (in ASCOT-LLA) - Figure 1

Figure 2: Effect of Atorvastatin Calcium 10 mg/day on Time to Occurrence of Major Cardiovascular Event (myocardial infarction, acute CHD death, unstable angina, coronary revascularization, or stroke) - Figure 2

Figure 2: Effect of Atorvastatin Calcium 10 mg/day on Time to Occurrence of Major Cardiovascular Event (myocardial infarction, acute CHD death, unstable angina, coronary revascularization, or stroke) - Figure 2

This is a graph showing the cumulative hazard percentage (%) for patients taking Atorvastatin, with a hazard ratio (HR) of 0.63 for the time period of four (4) years. The X-axis represents the time to the first primary endpoint. There is some text that appears to be garbled or incorrect, reading as "Placeho" and "--."*

Figure 3: Effect of Atorvastatin Calcium 80 mg/day vs. 10 mg/day on Time to Occurrence of Major Cardiovascular Events (TNT) - Figure 3

Figure 3: Effect of Atorvastatin Calcium 80 mg/day vs. 10 mg/day on Time to Occurrence of Major Cardiovascular Events (TNT) - Figure 3

This appears to be a table or a graph with some medication names and numbers. The content is not clear and may require additional context to provide a useful description.*

Structural Formula - Structure

Structural Formula - Structure

d4ec0525 42cb db55 e053 2995a90a607d 00

d4ec0525 42cb db55 e053 2995a90a607d 00

This is a description of Atorvastatin Calcium tablets, USP 40 mg that comes in a package of 10 film-coated tablets. The package is not child-resistant and is intended for institutional use only. The usual dosage instructions can be found in the product insert along with the necessary precautions and warnings. It should be stored at a temperature between 20° to 25° C (68° to 77° F) with excursions permitted between 15° to 30° C (59° to 86° F). This drug should be kept out of the reach of children, and if dispensed for outpatient use, it should be in child-resistant containers. If the blister is torn or broken, do not use it for your protection. It has been packaged and distributed by an Amerisource Bergen Company. The text is readable.*

d4ec0525 42cb db55 e053 2995a90a607d 01

d4ec0525 42cb db55 e053 2995a90a607d 01

These are Atorvastatin Calcium tablets, USP 20 mg, with ten tablets per package. The product insert should be reviewed for full prescribing information and warnings. The tablets should be stored between 20-25° C (68 to 77°F), with short excursions permitted between 15-30°C (59° to 86°F), according to USP Controlled Room Temperature. Although not child-resistant and intended for institutional use, a child-resistant container must be utilized for outpatient use. This package should be kept away from the reach of children, and the drug product should not be used if the blister is torn or broken. Packaged and distributed by American Health Packaging, Columbus, Ohio, a Cardinal Health company. NDC # 60505-2579.*

d4ec0525 42cb db55 e053 2995a90a607d 02

d4ec0525 42cb db55 e053 2995a90a607d 02

This is a package of MM x101 Atorvastatin Calcium Tablets, USP 10mg which contains 10 film-coated tablets equivalent to 10mg of Atorvastatin per tablet. The usual dosage, precautions, warnings, and other important information can be found in the product insert. These tablets should be stored within a controlled room temperature of 20° to 25° C (68° to 77° F) with excursions permitted between 15° to 30° C (59° to 86° F). The package is not child-resistant and intended for institutional use only. It is important to keep this and all drugs out of the reach of children. A child-resistant container should be used if dispensed for outpatient use. The product is manufactured by Apotex Corp. and packaged and distributed by American Health Packaging, an AmerisourceBergen Company.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.